Bryn Mawr Trust CO Arch Therapeutics, Inc. Transaction History

Bryn Mawr Trust CO

  • $2.54 Billion
  • Q1 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 15, 2018
BUY
$0.28 - $0.51 $4,200 - $7,650
15,000 New
15,000 $5,000

About Arch Therapeutics, Inc.

ARTH Quotes by TradingView
  • Ticker ARTH
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,886,000
  • Market Cap $240M
  • Description
  • Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flag...
More about ARTH
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email